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Malignant middle cerebral artery (MCA) stroke has a disproportionately high mortality due
to the rapid development of refractory space-occupying cerebral edema. Animal models are
essential in developing successful anti-edema therapies; however to date poor clinical
translation has been associated with the predominately used rodent models. As such, large
animal gyrencephalic models of stroke are urgently needed. The aim of the study was to
characterize the intracranial pressure (ICP) response to MCA occlusion in our recently
developed ovine stroke model.
Materials and Methods
30 adult female Merino sheep (n = 8–12/gp) were randomized to sham surgery, temporary
or permanent proximal MCA occlusion. ICP and brain tissue oxygen were monitored for 24
hours under general anesthesia. MRI, infarct volume with triphenyltetrazolium chloride
(TTC) staining and histology were performed.
Results
No increase in ICP, radiological evidence of ischemia within the MCA territory but without
space-occupying edema, and TTC infarct volumes of 7.9+/-5.1% were seen with temporary
MCAO. Permanent MCAO resulted in significantly elevated ICP, accompanied by 30%mor-
tality, radiological evidence of space-occupying cerebral edema and TTC infarct volumes of
27.4+/-6.4%.
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Conclusions
Permanent proximal MCAO in the sheep results in space-occupying cerebral edema, raised
ICP and mortality similar to human malignant MCA stroke. This animal model may prove
useful for pre-clinical testing of anti-edema therapies that have shown promise in rodent
studies.
Introduction
Malignant middle cerebral artery (MCA) stroke is associated with rapid neurological deteriora-
tion secondary to space-occupying cerebral edema following large volume MCA territory
infarction [1]. It accounts for 10–15% of all supratentorial strokes but a disproportionately
high 30-day mortality rate of 60–80% [2, 3], compared with approximately 20% for all ischemic
strokes [4]. Death results from rapid edema formation, raised intracranial pressure (ICP) and
transtentorial herniation, typically within 2–5 days of stroke onset, but often as early as 24
hours [1, 3, 5]. Despite this, current medical intervention for cerebral edema is limited to the
use of osmotic diuretics or invasive surgery with decompressive craniectomy [5]. Pharmaco-
therapies such as mannitol and hypertonic saline aim to dehydrate the swollen brain by draw-
ing out excess fluid into the vasculature [5]. Overall, these current non-surgical therapies are
ineffective or inadequate [5]. Decompressive craniectomy is a powerful surgical tool whereby a
flap of bone is removed overlying the swollen brain tissue to provide room for the expansion of
the swollen brain and reduce dangerously elevated ICP. Although decompressive craniectomy
significantly reduces the number of dead or severely disabled patients following malignant
MCA stroke [6], it is also a highly invasive procedure and not without its own morbidity and
mortality [7]. As such, alternate non-surgical treatments for cerebral edema and elevated ICP
are urgently required. However, to date there has been very poor translation of therapeutics
from experimental models to the clinical setting to date [8], clearly this disconnect needs to be
addressed and alternate approaches are urgently required to improve outcome and survival for
stroke patients. More rigorous pre-clinical testing is likely to facilitate this outcome.
A number of factors may have attributed to the lack of clinical translation of experimental
therapeutics, one of which is the choice of animal model. Rodent models of MCA occlusion
(MCAO) are widely used, in particular the intraluminal thread model [9]. Our understanding
of the pathophysiological mechanisms of cerebral ischemia at a cellular and molecular level has
increased considerably due to knowledge gained from such rodent stroke models[10]. How-
ever, given the gross neuroanatomical differences between small animal lissencephalic brains
and large animal/human gyrencephalic brains, such small animal models do not accurately
reproduce the intracranial pathophysiology which occurs after large cerebral insults in humans
[11]. This is particularly relevant in the context of space-occupying lesions and raised ICP, in
which the rodent brain is frequently associated with an inconsistent ICP response and low/var-
iable mortality despite very large insults [11–13].
An ovine model of gyrencephalic MCAO has previously been characterized, including
descriptions of magnetic resonance imaging (MRI), positron emission tomography, behavioral
phenotyping and histopathology after permanent occlusion of one branch, two branches or the
main MCA trunk [14]. More recently, we have described the surgical approach to sheep proxi-
mal MCA occlusion, demonstrating almost complete MCA territory ischemia following per-
manent proximal MCAO and smaller lesions with transient occlusion and reperfusion [15].
We observed histological evidence of large areas of ischemia, blood-brain barrier (BBB)
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dysfunction and early edema development but no elevation in ICP or radiological evidence of
space-occupying edema or cerebral herniation and this was due to the short 4 hour time period
examined. We propose that in this large animal model of stroke, a longer monitoring period
may reproduce the intracranial pathophysiological changes observed in human MCA territory
stroke such as elevated intracranial pressure and herniation syndromes. As such, the aim of the
current study was to fully characterize the ICP (primary objective), radiological and histopath-
ological (secondary objectives) response to permanent and transient ovine proximal MCAO at
24 hours after stroke onset. In this paper we demonstrate that this model is a good candidate
for screening of potential therapeutics prior to clinical assessment.
Experimental Procedure
Ethics Statement
All studies were approved by the Animal Ethics Committees of the University of Adelaide
(Approval M-2010-125) and SA Pathology (Approval #44/10). All experiments were con-
ducted in accordance with the Australian National Health and Medical Research Council code
of practice for the care and use of animals for scientific purposes (8th edition, 2013). Animals
remained under general anesthesia for the entire duration of the experiment and did not expe-
rience any pain or distress.
Animals and study design
30 adult female naïve wild-typeMerino sheep 18–36 months old (mean: 59.5 +/- 7.3kg; range:
45–73kg) were allocated to the study. Animals were group housed in the conventional sheep
paddocks at the Large Animal Research Facility (Gilles Plains, South Australia), with free
access to food, water and shelter. All animals were fasted overnight before the day of surgery.
Animals were intra-operatively randomized to one of three groups: permanent right proximal
MCAO (n = 10), 2 hours of temporary aneurysm clip right proximal MCAO followed by reper-
fusion (n = 12) or sham surgery (n = 8). Randomization was achieved by selection a pre-sealed
envelope (from a shuffled pile) which contained a surgery allocation card listing either sham,
permanent MCAO or transient MCAO. Animals underwent sham surgery or proximal MCAO
and were then monitored under general anesthesia for a 24 hour period for ICP (primary out-
come measure) and brain tissue oxygenation, followed by, infarct volume staining and histo-
logical assessment at the end of the monitoring period. Note that only a subset of animals
underwent MRI (permanent MCAO n = 6; temporary MCAO n = 6). The primary outcome
measured was intracranial pressure and the secondary outcomes measured were MRI charac-
terisitics, lesion volume and histological assessment.
Anesthesia
Anesthesia was induced with intravenous thiopentone (1000mg in 20mls, Jurox Pty Ltd, Aus-
tralia), animals were then intubated and maintained on inhalational isoflurane (1.5–3%; Veteri-
nary Companies of Australia) in a mixture of oxygen and room air, plus intravenous ketamine
infusion (4.0mg/kg/hour; Parnell Australia Pty Ltd, via a femoral line. Animals were main-
tained under general anesthesia for the entire duration of the experiment (~30 hours), as this
was a requirement of institutional ethical approval.
Physiological Monitoring
An arterial catheter was placed in the right femoral artery for continuous blood pressure moni-
toring and periodic arterial blood gas sampling. With the animal in the sphinx position, burr
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holes were placed symmetrically and a left hemisphere Codman ICP monitor (Codman &
Shurtleff Inc., MA) and right hemisphere brain tissue oxygen (PbtO2) LICOX probe (Integra
LifeSciences, NJ) were inserted, as previously described in detail [15]. In addition to the estab-
lished protocol, intramuscular antibiotics (Cephalexin 15mg/kg, Virbac Pty Ltd, Australia)
were administered at induction and 12 hourly until the end of the experiment, an indwelling
urinary catheter was inserted for urine collection and output measurement, and intravenous
fluids were administered as an infusion via the femoral venous catheter (Hartmann’s solution
4mL/kg/h, Baxter Pty Ltd, Australia). To maintain a neutral acid-base status, the strongly alka-
line saliva drool was collected and periodically returned via an orogastric feeding tube, and
sodium bicarbonate 8.4% (Pfizer Australia Pty Ltd, Australia) was added to the intravenous
infusion as required. Core body temperature was monitored and normothermia was main-
tained with a heating pad and blankets. Animals were monitored under general anesthesia as
previously described [15] for 24 hours after MCAO or sham surgery and their mean arterial
blood pressure, ICP, brain tissue oxygenation recorded. Periodic blood analysis was conducted
to confirm physiological pH and arterial oxygen and carbon dioxide partial pressures, with
ventilation parameters adjusted as required. Such physiological monitoring was initiated fol-
lowing induction of general anesthesia and was continued for a 24hour period following stroke
or sham surgery induction.
Surgical Approach to Proximal Middle Cerebral Artery Occlusion
We have previously described the surgical approach to proximal MCA occlusion in detail [15].
Briefly, a 50mm vertical incision was made behind the right eye, terminating at the zygomatic
arch. The underlying muscle was retracted, coronoid process removed and underlying skull
revealed. A small craniotomy was performed at the junction of the parietal and squamous tem-
poral bones with a high-speed pneumatic drill using a 5mm cutting burr (Midas Rex, Medtro-
nic, MN). A horse-shoe shaped durotomy was performed with an inferiorly based flap. All
intra-dural work was carried out with loupe magnification and a head mounted light source
(Surgical Acuity, WI). The proximal MCA was location by gentle upwards retraction of the
anterior temporal lobe. Animals then underwent either 1) sham surgery, in which the proximal
MCA was dissected but not occluded; 2) permanent occlusion in which the proximal MCA was
occluded via Malis bipolar diathermy forceps (ValleyLab Inc, CO); or 3) temporary occlusion
with reperfusion, in which the proximal MCA was occluded with application of a Sugita tem-
porary mini straight aneurysm clip (Mizuho Medical Inc, Japan) which was removed 2h later.
The exposed brain was irrigated with saline during surgery to prevent drying out of the cerebral
cortex, particularly in temporary occlusion animals where there was a 2h delay between aneu-
rysm clip application and wound closure. After the completion of sham or MCA occlusion sur-
gery the dura was approximated and closed watertight with ethyl cyanoacrylate (Bostik,
Australia) and reinforced with dental acrylic cement (Lang Dental, IL) that was manipulated
into the edge of the craniotomy, maintaining the shape of the cranial cavity and importantly,
the homeostasis of ICP dynamics. The wound was closed in layers and the head was then
returned to a neutral position for monitoring under general anesthesia.
Magnetic Resonance Imaging
At 24 hours following stroke onset, a subgroup of animals (permanent MCAO n = 6, tempo-
rary MCAO n = 6) underwent imaging in a 1.5T Siemens Sonata MRI scanner (Siemens AG,
Munich, Germany) using the protocol previously described [15]. Radiological infarct volume
was calculated as a percentage of whole brain on coronal section using the diffusion weighted
images (DWI), corrected for edema using a modified Swanson calculation [16]. Cerebral
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edema was calculated on coronal T2 weighted imaging sequences (T2WI) as a percentage of
whole brain uncorrected. Midline shift was assessed on axial T1 weighted imaging sequences
(T1WI), and measured in millimeters at the level of the interventricular foramen. Cerebral her-
niation and brainstem compression was identified on axial and sagittal T1WI.
Histological Examination and Infarct Volume Assessment
At the end of the 24 hour monitoring period, or after MRI, animals were administered intrave-
nous heparin (5000I.U./5ml; Pfizer, NY) and killed via common carotid perfusion fixation
with cold TRIS-buffered saline under Isoflurane anesthesia. The brains were subsequently rap-
idly removed, sliced into 10mm coronal slices using a custom made matrix, and 2,3,5-triphe-
nyltetrazolium chloride (TTC; Sigma-Aldrich Pty Ltd, Australia) staining performed to
determine infarct volume, as previously described in rodent stroke [17]. On the TTC stain,
non-infarcted tissue stains red/pink in color and infarcted tissue remains a pale cream/white
color. Brain slices were incubated in 3% TTC at 37°C under dark room conditions for 20 min,
turning once. Anterior and posterior sides of all brain slices were photographed on a flatbed
scanner (Canon CanoScan LiDE700F, Canon Inc., Japan). The degree of infarction was deter-
mined by an observer blinded to the surgery groups and experienced in the evaluation of
infarct determination, with infarct volume calculated as a percentage of whole brain corrected
for edema via the modified Swanson calculation [16]. Sections were then immersion fixed in
10% neutral-buffered formalin for a minimum of 7 days prior to being processed for histologi-
cal examination by H&E, albumin (dilution 1:2000, Dako, Glostrup, Denmark) immunohis-
tochemistry, and Weil’s stain (myelin degeneration). TUNEL assays were performed using a
modified technique of the method of Portera-Cailliau et al. [18] (TdT 0.15 U/μl; Promega,
Madison, WI; and biotin-16-dUTP, 10 μM; Roche, Castle Hill, Australia).
Statistical Analysis
Data analysis was conducted by an individual blinded to the surgery group allocation (sham,
temporary MCAO and permanent MCAO). All data is expressed as mean +/- standard devia-
tion, with the exception of the ICP and PbtO2 results, which were not normally distributed and
did not have uniform variance. Raw ICP and PbtO2 raw data underwent a logarithmic expo-
nential transformation and were then expressed as geometric mean with standard deviation
[19]. Physiological data (arterial blood pressure, ICP, PbtO2, PaO2, PaCO2, core body tempera-
ture) was analyzed using two-way analysis of variance followed by individual Bonferroni tests
(Prism Version 5.0d, Graphpad, CA). Physiological parameters were analyzed pre-MCAO or
sham surgery, and at hourly intervals until the completion of the experiment, with the excep-
tion of arterial blood gas data that was collected every 4 hours. Lesion volume data, TUNEL
area of immunoreactivity/cell counts and MRI characteristics were analyzed by individual stu-
dent t-tests. A p-value of p<0.05 was considered significant. All animals were included in the
analysis.
Results
Surgery, Mortality and Basic Physiology
There were no surgical complications and no animals were excluded from the analysis due to
technical complications with the procedure. All sham and temporary MCAO animals survived
the 24 hour monitoring period. Of the permanent MCAO animals, 3/10 (30%) died prema-
turely secondary to raised ICP and brainstem compression. Mean arterial blood pressure,
PaO2, PaCO2 and core body temperature were within physiological parameters, on the whole
ICP Post-Stroke in an Ovine Model
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there were no difference between groups throughout the 24 hour monitoring period. Of excep-
tion, were those animals which died prematurely, their physiological responses were character-
ized initially by an elevation in mean ICP and widening of the ICP pulse amplitude, followed
by a rise and then fall in end tidal CO2, and finally arterial hypotension and cardiac arrest.
Mean time to death in animals dying prematurely was 19h39min +/- 2h55min (range:
16h20min–22h30min). One of the non-survivors had MRI examination at the point of arterial
hypotension but prior to cardiac arrest. Such mortality is representative of the human condi-
tion and therefore a clinically relevant feature of the model. In light of this, the surgical
approach to MCAO was not altered in order to reduce this figure.
Intracranial Pressure
ICP monitoring was conduced in n = 8 shams, n = 12 temporary and n = 10 permanent
MCAO animals. The mean pre-operative ICP was 6.4 +/- 1.9mmHg, with no difference
between groups (Fig 1A). ICP rose above pre-operative levels in the sham group and was main-
tained at approximately 10mmHg for the duration of the monitoring period. In temporary
MCAO animals, ICP rose slightly higher to 13.0 +/- 2.0mmHg by 24 hours, however with no
overall significant difference compared with sham animals. After permanent MCAO, ICP rose
significantly compared with sham (p<0.0001), and remained elevated for the duration of the
monitoring period with a continuous upward trend. Permanent MCAO animals that died pre-
maturely (Fig 1B) also had a significantly elevated mean ICP compared with permanent
MCAO animals that survived (27.0 +/- 1.3mmHg vs. 18.5 +/- 1.3mmHg, p<0.0001), which
was sustained for the duration of the monitoring period.
Brain Tissue Oxygen
PbtO2 monitoring was conduced in n = 8 shams, n = 12 temporary and n = 10 permanent
MCAO animals. The mean baseline PbtO2 for all animals was 45.4 +/- 1.3mmHg, with no dif-
ference between groups (Fig 1C). In sham animals, PbtO2 showed a gradual decline over the
first 8 hours, to eventually plateau at approximately 30–35mmHg for the remainder of the
experiment. In temporary occlusion animals baseline PbtO2 was 44.8 +/- 1.4mmHg prior to
aneurysm clip application, falling to 10.1 +/- 2.3mmHg 2 hours after MCAO, immediately
prior to clip removal and reperfusion (p<0.0001). It then rapidly rose to 22.5 +/- 2.2mmHg 1
hour after reperfusion, then gradually climbed to 29.1 +/- 2.5mmHg 9 hours following reperfu-
sion, at which point any difference to sham lost significance. Temporary MCAO PbtO2 pla-
teaued at approximately 28–30mmHg for the remainder of the experiment. Permanent
occlusion animals demonstrated a baseline of 45.6 +/- 1.4mmHg, which declined significantly
following MCAO to a low of 7.0 +/- 2.3mmHg at 8 hours (p<0.0001), and continued to stay
low to eventually plateau at approximately 7mmHg by 24 hours (p<0.0001). Permanent
MCAO PbtO2 remained the lowest of all three groups at the conclusion of the experiment,
with temporary MCAO approaching sham levels.
MRI
MRI was performed in 6/10 permanent MCAO and 6/12 temporary MCAO animals; MRI
characteristics are shown in Table 1. MRA confirmed no flow beyond the proximal MCA in all
permanent MCAO animals (Fig 2C), and reperfusion of the right MCA territory in all tempo-
rary MCAO animals (Fig 2A). The mean DWI deficit for permanent MCAO (Fig 2D) animals
was 25.4 +/- 6.8%, compared with 10.7 +/- 3.9% for temporary MCAO (Fig 2B) animals (p =
0.001). Cerebral edema measured on coronal T2WI revealed a mean volume of 25.0 +/- 4.9%
for permanent MCAO animals, and 5.4 +/- 4.1% for temporary MCAO animals (p<0.0001,
ICP Post-Stroke in an Ovine Model
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Fig 3A and 3D). Mean midline shift was 3.3 +/- 0.6mm for permanent MCAO animals (Fig
3E), compared with 1.0 +/- 0.8mm for temporary MCAO animals (Fig 3B; p = 0.0002). None
of the temporary MCAO animals demonstrated transtentorial herniation or brainstem com-
pression (Fig 3C), whereas herniation was present in 3 out of 6 (50%) permanent MCAO
animals, seen on MRI as crowding around the foramen magnum, effacement of the cisterna
magna and tonsillar herniation (Fig 3F). These animals also demonstrated significant local
mass effect with sulcal effacement. Permanent MCAO animals that herniated (n = 3, including
1 animal that died prematurely) demonstrated a mean DWI lesion volume of 27.7 +/- 5.5%, a
mean T2WI edema volume of 27.4 +/- 3.6%, and mean midline shift of 3.6 +/- 0.5mm; perma-
nent MCAO animals that did not herniate (n = 3, all survived) demonstrated a mean DWI
lesion volume of 23.2 +/- 8.4% (p = 0.479), a mean T2WI edema volume of 22.6 +/- 5.4%
(p = 0.269), and mean midline shift of 3.0 +/- 0.7mm (p = 0.298).
Infarct Volume
TTC staining was performed in 5/6 sham animals, 11/12 temporary MCAO animals, and 8/10
permanent MCAO animals. There was no TTC evidence of infarction in any of the sham ani-
mals (Fig 4B). All temporary MCAO animals demonstrated TTC pallor within the right MCA
cortex (Fig 4A); subcortical structures were involved in 6 of 11 animals, most frequently affect-
ing the head of caudate nucleus. The mean TTC infarct volume for temporary MCAO was
7.9 +/- 5.1%. Permanent MCAO (Fig 4C) animals demonstrated significantly larger TTC
infarct volumes that generally affected the whole MCA supplied cortex and typically most of
Fig 1. Mean 24 hour ICP and PbtO2 following MCAO.Mean ICP following sham surgery, temporary MCAO
or permanent MCAO (A). Mean ICP following permanent MCAO, animals that died within the 24-hour
monitoring period versus animals that survived (B). Mean PbtO2 following temporary and permanent MCAO
or sham surgery (C). ICP, intracranial pressure; MCAO, middle cerebral artery occlusion; PbtO2, partial
pressure of brain tissue oxygen, n = 8–12/gp.
doi:10.1371/journal.pone.0130512.g001
Table 1. MRI characteristics and TTC infarct volume at 24 hours after MCAO.
Stroke Type MRI characteristics at 24 hours
Animal TTC infarct volume (%) DWI volume (%) T2WI volume (%) Midline shift (mm) Herniation (Y/N)
Permanent MCAO 1* 30.9 33.8 31.5 3.8 Y
2 32.8 32.4 26.1 3.1 N
3 24.9 23.3 24.7 4.1 Y
4 23.8 21.0 25.3 3.4 N
5 14.1 16.1 16.3 2.5 N
6 28.1 25.9 26.0 3.1 Y
Mean ±SD 25.76 ±6.66 25.41 ±6.78 24.98 ±4.90 3.33 ±0.56
Transient MCAO 7 2.6 14.7 2.3 0 N
8 14.1 7.5 3.7 0.9 N
9 5.8 13.9 5.1 1.6 N
10 4.8 7.1 1.9 1.6 N
11 0.9 7.0 5.9 0 N
12 12.4 14.1 13.2 1.9 N
Mean ±SD 6.76 ±5.33 10.71 ±3.86 5.35 ±4.14 1 ±0.8
*Animal 1 died prematurely at 16h40min. DWI, diffusion weighted imaging; MCAO, middle cerebral artery occlusion; MLS, midline shift; MRI, magnetic
resonance imaging; T2WI, T2 weighted imaging; TTC, tetrazolium chloride.
doi:10.1371/journal.pone.0130512.t001
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the subcortical structures (caudate, putamen, thalamus), with mean TTC infarct volumes of
27.4 +/- 6.4% (p<0.0001). One permanent MCAO animal demonstrated infarction in the con-
tralateral posterior cerebral artery territory (PCA), attributed to raised ICP, uncal herniation
and occlusion of the PCA on its passage through the tentorial notch. This animal died prema-
turely at 20 hours following MCAO and had a highest mean ICP of 63.1 +/- 7.8mmHg with a
pulse amplitude of 24.7mmHg in the hour prior to death. Animals that herniated on MRI
tended to have larger TTC infarct volumes than permanent MCAO animals that did not herni-
ate (27.9 +/- 3.0% vs. 23.6 +/- 9.4%, p = 0.485) but this was not statistically significant.
Histological Assessment
Histopathological examination revealed different patterns of injury between the two MCAO
groups (Figs 5 and 6). With the exception of TUNEL staining (n = 3 temporary MCAO, n = 3
permanent MCAO) all histopathology was conducted in all animals (n = 8 sham, n = 12 tem-
porary MCAO, n = 10 permanent MCAO). Temporary MCAO (Fig 5B) sections stained for
H&E demonstrated discrete regions of infarct whereas permanent MCAO (Fig 5C) demon-
strated larger infarct corresponding to TTC examination (Fig 4). On closer examination, cells
within the infarct core were shrunken, abnormally shaped and vacuolated (Fig 6A), whereas
Fig 2. MRI findings at 24 hours following stroke: MRA and DWI. Temporary MCAOMRA demonstrates
reperfusion in the right MCA territory (A), and diffusion deficit on DWI in the right MCA cortex (B). Permanent
MCAOMRA shows no flow beyond the right proximal MCA (C), and a larger diffusion deficit involving the
whole MCA territory including subcortical structures (D). DWI, diffusion weighted imaging; MCA, middle
cerebral artery; MCAO, middle cerebral artery occlusion; MRA, magnetic resonance angiography, n = 6/gp.
doi:10.1371/journal.pone.0130512.g002
ICP Post-Stroke in an Ovine Model
PLOS ONE | DOI:10.1371/journal.pone.0130512 June 29, 2015 9 / 20
there was greater preservation of tissue architecture and cell integrity in the penumbra (Fig
6B). The Weil stain (Fig 5) was used to show myelin degeneration. Transient MCAO (Fig 5H)
resulted in discrete regions of myelin loss, whereas permanent MCAO (Fig 5I) produced large
areas of myelin loss, corresponding to the large size of the infarcts seen with TTC staining and
on H&E. TUNEL staining, a marker of cell death, showed widespread immunoreactivity within
permanent MCAO tissue compared with transient MCAO tissue (Fig 7A and 7B). Indeed, the
number of TUNEL positive cells (9588+/-1948 vs. 2702+/- 989; p<0.05) and the total area of
positive TUNEL staining (115+/-6.87 vs. 31.86+/-7.99; p<0.01) were both significantly higher
following permanent compared to transient MCAO (Fig 7E and 7F), once again in keeping
with the infarct volume data. TUNEL positive cells (Fig 7C) were observed throughout the
infarct following both transient and permanent MCAO (Fig 7D). Albumin immunohistochem-
istry was used as a marker of BBB disruption and a surrogate marker of vasogenic edema.
Small regions of albumin immunoreactivity were apparent in transient MCAO tissue, com-
pared with large regions in the permanent MCAO tissue (Fig 5D, 5E and 5F) and corresponded
well with MRI T2WI evidence of edema (Fig 3A and 3D).
Discussion
Decompressive craniectomy for malignant MCA stroke improves early survival and outcome
by preventing brainstem compression secondary to transtentorial herniation [7]. Novel
Fig 3. MRI findings at 24 hours following stroke: T1 and T2 weighted imaging. Temporary MCAO demonstrates cerebral edema in a right MCA
distribution similar to the diffusion deficit in Fig 2B on T2 coronal imaging (A), and no mass effect or midline shift on T2 axial imaging (B). Sagittal T1
sequences show preserved basal cisterns and posterior fossa CSF spaces (C). T2 coronal (D) and axial (E) imaging after permanent MCAO show cerebral
edema distributed as for the diffusion deficit in Fig 2D, with associated mass effect and midline shift. Sagittal T1 imaging demonstrates effacement of the
basal cisterns and cisterna magna, tonsillar herniation and brainstem compression (F). MCA, middle cerebral artery; MCAO, middle cerebral artery
occlusion, n = 6/gp.
doi:10.1371/journal.pone.0130512.g003
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therapies limiting BBB permeability [20] and vasogenic edema [21, 22] after rodent ischemic
stroke have proven to be as effective as or superior to surgical decompression. However, the
marked differences between rodent and human intracranial anatomy, particularly the delicate
rodent tentorium cerebelli [11, 23, 24], make translation of pathology involving raised ICP and
transtentorial herniation difficult. Following the poor clinical translation of promising treatments
developed in rodent models, the STAIR guidelines [25] recommend that neuroprotective
Fig 4. TTC at 24 hours, coronal stack.Unstained brain tissue represents cerebral ischemia. There is no
evidence of ischemia in sham animals in the left column (A), small cortical ischemia in temporary MCAO
animals in the center column (B), and large MCA territory ischemia in permanent MCAO animals in the right
column (C). MCA, middle cerebral artery; MCAO, middle cerebral artery occlusion; TTC,
2,3,5-triphenyltetrazolium chloride, n = 5 shams, n = 11 transient MCAO, n = 8 permanent MCAO.
doi:10.1371/journal.pone.0130512.g004
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agents be tested in gyrencephalic species following initial rodent studies [8]. The neuroanatom-
ical properties of the sheep [15], together with the physiological and histological outcomes we
have demonstrated, suggest that our ovine MCAOmodel is suitable for pre-clinical testing
after preliminary rodent studies in order to confirm efficacy prior to progression to clinical
assessment.
Our ovine stroke model fulfills numerous STAIR criteria [25], allowing for extensive physio-
logical monitoring including arterial blood pressure and blood gas analysis, multiple blood
draws from the same animal at multiple time points, electrolyte and renal function, hemoglo-
bin and hematocrit, fluid balance and core body temperature. An additional advantage is that
it allows for reperfusion and we have investigated the effects of MCAO in female animals. Fur-
thermore, we have demonstrated multiple outcome measures for proximal MCAO in the
sheep, including physiological (ICP, PbtO2), radiological (DWI infarct volume, T2WI edema,
midline shift and herniation syndromes) and pathological (TTC and immunohistopathology).
We observed early mortality in 30% of sheep within 24 hours of permanent MCAO, secondary
to cerebral herniation and brainstem compression, consistent with previous non-human
Fig 5. Histopathology, coronal section. Section level with the origin of the MCA. H&E for sham surgery (A), temporary MCAO (B) and permanent MCAO
(C). Albumin immunostaining for sham (D), temporary MCAO (E) and permanent MCAO (F). Weil stain for sham (G), temporary MCAO (H) and permanent
MCAO (I). MCA, middle cerebral artery; MCAO, middle cerebral artery occlusion, n = 8 shams, n = 12 transient MCAO, n = 10 permanent MCAO.
doi:10.1371/journal.pone.0130512.g005
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primate models and large volume human stroke, making this model a powerful tool for investi-
gating therapies targeting malignant cerebral edema and mortality. Although, such mortality
in combination with the extensive extra-cranial dissection required to reach the proximal
MCA, may be problematic for long-term survival studies.
ICP
Our study is the only report of ICP after permanent and temporary MCAO in a gyrencephalic
species for a clinically relevant minimum 24 hours. Several studies have described ICP after
rodent stroke, however measurements tend to be taken from within the posterior fossa [13,
26]. Although due to the underdeveloped tentorium in the rat an infratentorial ICP monitor is
probably an accurate reflection of supratentorial pressure following space-occupying cerebral
edema. Nevertheless, the lack of significant compartmentalization between the cerebrum and
cerebellum makes transtentorial herniation following rodent MCAO unlikely. Despite this,
rodent MCAO is associated with space-occupying cerebral edema and midline shift [27]. In
rodent stroke, decompression improves mortality rates and neurological function [28],
Fig 6. Histopathology for H&E. The infarct was evident as a region of tissue pallor, charcterised by
extensive cell injury/death and tissue vacuolation (A). The was selective cell sparing and cell injury/loss within
the penumbral tissue (B). n = 8 shams, n = 12 transient MCAO, n = 10 permanent MCAO.
doi:10.1371/journal.pone.0130512.g006
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suggesting that following large volume rodent MCA stroke ICP is still a contributing factor to
outcome. Studies investigating ICP after ischemic stroke in gyrencephalic species include cats,
dogs and baboons, however almost all have reported relatively short monitoring periods of
only 6–12 hours post-stroke [29–31]. O’Brien and Waltz performed transorbital MCAO in cats
and measured ICP for up to 15 days with technical difficulties [32]. ICP data from the present
study differed slightly from our previous study where ICP was measured up to 4 hours follow-
ing stroke onset. In our previous study, differences in ICP were not observed during the 4 hour
monitoring period, whereas they were evident as early as 3 hours post-stroke onset in the pres-
ent study. Possible explanations for these differences include surgical experience and improved
technique, and the logarithmic exponential transformation with geometric mean data analysis
used in the present study, both of which may result in more accurate data collection and analy-
sis compared with the previous study.
Raised ICP is used frequently used as an outcome measure in clinical and experimental
studies of traumatic brain injury but is less commonly in acute stroke, where elevated ICP is
generally identified by radiological or clinical findings. Nevertheless, intracranial hypertension
is a cause of early in-hospital mortality in28.9% of stroke unit admissions (Koennecke et al,
2011). Hacke’s [3] original description of malignant MCA infarction included 26 patients with
epidural ICP monitoring, assessing the efficacy of anti-edema therapy and barbiturate coma
after radiological identification of space-occupying edema. Baseline ICP was 19.4mmHg, and
over 4–10 days the average highest ICP recorded in patients that died was 43mmHg compared
with 28mmHg in survivors. Ropper and Shafran [33] reported their ICP findings in 6 patients
in an earlier series, and a larger series by Schwab suggested ICP>35mmHg was a poor prog-
nostic sign [34]. However, the clinical usefulness of ICP monitoring for ischemic stroke is ques-
tionable at best and is not as useful an indicator to perform surgical decompression as clinical
and neuroimaging findings [34]. However, in an experimental setting ICP monitoring is simple
to perform and provides a quantifiable numerical value from which the physiological
Fig 7. TUNEL staining. TUNEL immunoreactivity, indicative of cell death, was observed throughout the
infarcted tissue. The region of TUNEL immunoreactivity was larger and more widespread following
permanent (B) than transient MCAO (A). TUNEL positive cells (C) were observed throughout the infarcted
tissue, typically seen in areas of tissue vacuolation and extensive cell injury (D). The number of TUNEL
positive cells (E) and total area of TUNEL immunoreactivity (F) was significantly higher following permanent
than transient MCAO. n = 3/gp.
doi:10.1371/journal.pone.0130512.g007
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effectiveness of anti-space-occupying edema therapies can be assessed. Indeed, our post-stroke
ICP monitoring revealed that our ovine MCAOmodel produced ICP elevations comparable to
that observed clinically [3, 33, 34].
PbtO2
We have previously characterized the regional PbtO2 response to permanent and temporary
MCAO in the sheep, albeit only for 4 hours [15]. Nevertheless, we demonstrated reduced
PbtO2 following temporary occlusion that returned to sham levels 30 minutes following reper-
fusion, and a sustained reduction in PbtO2 following permanent MCAO. The present study
produced similar results but with some important differences. Firstly, it took 7 hours for PbtO2
in temporary MCAO to approach and become comparable with shams, more than 6 hours lon-
ger than our initial study. Secondly, temporary MCAO PbtO2 levels fell much lower in the
present study, almost to permanent MCAO levels, and in fact declined faster than the perma-
nent MCAO group. Possible explanations for these differences include surgical experience and
improved technique, and the logarithmic exponential transformation with geometric mean
data analysis used in the present study, both of which may result in more accurate data collec-
tion and analysis compared with the previous study. PbtO2 levels in sham animals were not
entirely stable throughout the 24 hour monitoring period, this may be attributable to the fact
that the probe can take several hours to equilibrate once inserted into the brain parenchyma
and/or the influence of oxygen levels within the anesthesia gas delivery mix.
MRI
The development of a malignant course following MCA stroke is frequently associated with
large infarct volume, however inflammation and BBB breakdown may also be important
parameters [35]. Large territory human MCA infarct volumes, such as DWI infarct volume
>145cm3 [36] or Computerized Tomography ischemic changes affecting at least two-thirds of
the MCA territory with basal ganglia involvement [37]) or space-occupying edema [38] are
predictive of a malignant course and improved outcome following surgical decompression [6].
Indeed, our permanent MCAO findings are in keeping with such features of large MCA stroke
in humans. Midline shift is a frequently associated, albeit relatively late finding, with the degree
of midline shift correlating with edema volume in experimental rodent studies [27]. Compared
with the smaller temporary MCAO infarcts, we found that permanent MCAO produced a sig-
nificantly larger diffusion deficit and edema volume (approximately 25% of the supratentorial
brain), as well as radiological evidence of raised ICP secondary to focal space-occupying
pathology. Furthermore, permanent MCAO produced radiological evidence of raised ICP with
larger DWI, T2WI and TTC volumes. Such findings on MRI are observed in the setting of clin-
ical stroke and are a clinically relevant feature of our ovine model.
Histopathology
Ischemic injury on H&E for both permanent and temporary MCAOmirrored TTC and DWI
evidence of ischemia, and similarly the Weil stain (myelin degeneration) corresponded well
with T2WI cerebral edema. TUNEL staining confirmed widespread cell loss throughout the
infarcted hemisphere in permanent MCAO, compared to much smaller regions in the transient
MCAO group, as reflected by the H&E and TTC staining. Albumin extravasation confirmed
that disruption of the BBB and development of vasogenic edema is the main source of cerebral
edema in this model. Indeed, albumin extravasation was significantly more prevalent following
permanent MCAO compared with transient MCAO.
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Multiple techniques have been described to study transient and permanent MCAO in ani-
mal models, with the effects of MCAO varying considerably depending upon the species,
strain, method/duration of occlusion used. Here we describe a model of transient or permanent
MCAO in the sheep. Transient occlusion of the MCA followed by reperfusion after 2 hours
produced discrete, variable lesions characterized by small regions of BBB breakdown and cere-
bral edema, histopathology and MRI respectively. Transient MCAO in our ovine model pro-
duced a transient decline in PbtO2 levels that correlated with clip application and removal,
with ICP remaining within normal limits during this time. This model permits the study of
reperfusion injury associated with MCA occlusion and reperfusion. In contrast, permanent
MCAO in our ovine model produced large infarcts encompassing the entire MCA territory,
accompanied by widespread loss of BBB integrity, profound cerebral edema, significantly
increased ICP, accompanied by a sustained decline in PbtO2 levels and a mortality rate of 30%.
This permanent model is most appropriate for screening agents targeting cerebral edema and
elevated ICP following stroke.
Limitations
Although the findings suggest that this ovine model is a good candidate for pre-clinical screen-
ing of agents targeting cerebral edema and elevated ICP, the limitations of the study must be
acknowledged. Firstly, institutional ethical approval was granted on the condition that animals
remain under general anesthesia for the entire duration of the experiment, some 30 hours or
so. We acknowledge that human patients are rarely anesthetized at the time of stroke, in addi-
tion to the potential neuroprotective effects of anesthesia on experimental stroke model out-
comes. Indeed, many studies have now reported on the neuroprotective effects of anesthesia in
animal models of stroke [39]. Specifically, ketamine is suggested to have neuroprotective prop-
erties through inhibition of apoptosis proteins and modulation of the inflammatory response
[40]. Given that ketamine is a NMDA antagonist it may have influenced the extent of excito-
toxic brain damage. However, ketamine has the specific advantage of possessing analgesic
properties and although inhalational anesthetics are generally preferred for prolonged proce-
dures, combination inhalational/ketamine regimes have been popular for and successful in
anesthetizing small ruminants since the 1970s [41]. The addition of a low dose ketamine infu-
sion to sub-neuroprotective MCA isoflurane produced a synergistic relationship between the
two anesthetic agents, permitting as lower MCA isoflurane and therefore enabling good anes-
thesia and systemic blood pressure but avoiding inadvertent neuroprotection as a confounding
factor when characterizing the stroke model. Nevertheless, the experiments were conducted
within the constraints of the ethical approval requirements. Ideally, we would wake the animals
up following the induction of stroke and track progress in awake animals. In conjunction with
our ethics committees we are working to extend the model to permit long-term survival by
modifying the surgical approach, thereby obviating the need for long-term anesthesia and
allow the study of conscious animals following the induction of stroke. Furthermore, only
female animals were used in the current study. Using both male and female animals would
have been optimal but given the length of the experiment (~30 hours) with the animals under
general anesthesia the entire time meant that a urinary catheter needed to be inserted. Females
were selected preferentially over males upon veterinary advice given the difficulty in catheteriz-
ing the highly convoluted male urethra. Group sizes differed between stroke and sham groups.
Group sizes did not differ intentionally and were a direct reflection of animal availability due to
the age and weight range required. Only a subset of animals underwent MRI due to financial
constraints and access to the scanner. Although animals were randomly selected and were not
consecutive animals it would have been desirable to image each and every animal in the study.
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In the present study ICP was measured in the contralateral hemisphere to avoid overcrowd-
ing in the ipsilateral hemisphere. There is some experimental evidence suggesting that a signifi-
cant pressure gradient exists between hemispheres in gyrencephalic brains with unilateral
space-occupying pathology including large volume stroke [29], whereas others believe pressure
is transmitted uniformly within the supratentorial compartment [42]. A human case report
suggests that gradients may only be apparent at the time of decompensation and intracranial
shift [43]. Recording ICP in the right hemisphere may have yielded higher mean pressures, par-
ticularly after permanent MCAO, and bilateral recordings may have provided more informa-
tion on interhemispheric pressure gradients following MCA stroke. Nevertheless, our
contralateral recordings demonstrated a significant elevation in ICP following ischemic space-
occupying cerebral edema. Finally, the differences in ICP response between the permanent and
transient MCAO groups may have been influenced by the time to skull closure. In the perma-
nent MCAO animals the dura/skull was closed immediately after vessel occlusion whereas in
the transient group the dura/skull was left open for 2 hours during the occlusive period and
only closed upon reperfusion. This may have influenced the time to restoration of intracranial
dynamics, accumulation of CSF and ICP changes in response to the evolving infarct and any
associated tissue swelling.
Conclusions
We have demonstrated a malignant course following permanent proximal MCAO in an ovine
model, characterized by elevated ICP, space-occupying cerebral edema, large diffusion deficit
and a considerable mortality of 30% within 24 hours of stroke. Temporary MCAO with reper-
fusion produced smaller infarct volumes, localized cerebral edema without space-occupying
effect or ICP alterations. This model provides a powerful tool for the preclinical investigation
of novel therapies, particularly those targeting cerebral edema and elevated ICP. This model
may be used to supplement the currently used small animals models to validate agents of out-
standing promise prior to clinical assessment. We believe this step-wise progression of screen-
ing through small animal models then large animal models will increase the likelihood of
clinical success and improve translation of stroke therapeutics.
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